33 related articles for article (PubMed ID: 11226957)
1. Potential ferroptosis-related diagnostic and prognostic biomarkers in laryngeal cancer.
Ji Z; Fang Z; Dong X; Wang J; Wan X; Yan A
Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5277-5288. PubMed ID: 35829804
[TBL] [Abstract][Full Text] [Related]
2. MUC1 confers radioresistance in head and neck squamous cell carcinoma (HNSCC) cells.
Huang TQ; Bi YN; Cui Z; Guan JP; Huang YC
Bioengineered; 2020 Dec; 11(1):769-778. PubMed ID: 32662743
[TBL] [Abstract][Full Text] [Related]
3. MUC1: The First Respiratory Mucin with an Anti-Inflammatory Function.
Kato K; Lillehoj EP; Lu W; Kim KC
J Clin Med; 2017 Nov; 6(12):. PubMed ID: 29186029
[TBL] [Abstract][Full Text] [Related]
4. Distribution of mucins and antimicrobial substances lysozyme and lactoferrin in the laryngeal subglottic region.
Kutta H; Willer A; Steven P; Bräuer L; Tsokos M; Paulsen F
J Anat; 2008 Oct; 213(4):473-81. PubMed ID: 18657260
[TBL] [Abstract][Full Text] [Related]
5. Influence of sialic acid removal on MUC1 antigenic reactivity in head and neck carcinoma.
Croce MV; Rabassa ME; Pereyra A; Segal-Eiras A
Pathol Oncol Res; 2005; 11(2):74-81. PubMed ID: 15999150
[TBL] [Abstract][Full Text] [Related]
6. MUC1 mucin and carbohydrate associated antigens as tumor markers in head and neck squamous cell carcinoma.
Croce MV; Rabassa ME; Price MR; Segal-Eiras A
Pathol Oncol Res; 2001; 7(4):284-91. PubMed ID: 11882908
[TBL] [Abstract][Full Text] [Related]
7. Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior.
Yonezawa S; Goto M; Yamada N; Higashi M; Nomoto M
Proteomics; 2008 Aug; 8(16):3329-41. PubMed ID: 18651706
[TBL] [Abstract][Full Text] [Related]
8. Mucin expression profile in pancreatic cancer and the precursor lesions.
Nagata K; Horinouchi M; Saitou M; Higashi M; Nomoto M; Goto M; Yonezawa S
J Hepatobiliary Pancreat Surg; 2007; 14(3):243-54. PubMed ID: 17520199
[TBL] [Abstract][Full Text] [Related]
9. Expression of MUC1 and MUC2 glycoproteins in laryngeal cancer.
Jeannon JP; Aston V; Stafford FW; Soames JV; Wilson JA
Clin Otolaryngol Allied Sci; 2001 Apr; 26(2):109-12. PubMed ID: 11309050
[TBL] [Abstract][Full Text] [Related]
10. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.
Chhieng DC; Benson E; Eltoum I; Eloubeidi MA; Jhala N; Jhala D; Siegal GP; Grizzle WE; Manne U
Cancer; 2003 Dec; 99(6):365-71. PubMed ID: 14681945
[TBL] [Abstract][Full Text] [Related]
11. [Expression of mucin MUC1 and MUC2 in colorectal carcinoma and their clinical significance].
Huang WB; Shi LH; Zhu XQ; Xu GX; Qi Q
Ai Zheng; 2002 Nov; 21(11):1231-4. PubMed ID: 12526222
[TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
13. Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence.
Ho SB; Ewing SL; Montgomery CK; Kim YS
Oncol Res; 1996; 8(2):53-61. PubMed ID: 8859775
[TBL] [Abstract][Full Text] [Related]
14. Altered MUC1 and MUC2 glycoprotein expression in laryngeal cancer.
Jeannon JP; Stafford FW; Soames JV; Wilson JA
Otolaryngol Head Neck Surg; 2001 Feb; 124(2):199-202. PubMed ID: 11226957
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
